149 related articles for article (PubMed ID: 16565312)
1. Additive effects of combined blockade of AT1 receptor and HMG-CoA reductase on left ventricular remodeling in infarcted rats.
Lee TM; Lin MS; Chou TF; Chang NC
Am J Physiol Heart Circ Physiol; 2006 Sep; 291(3):H1281-9. PubMed ID: 16565312
[TBL] [Abstract][Full Text] [Related]
2. Effects of pravastatin on cardiomyocyte hypertrophy and ventricular vulnerability in normolipidemic rats after myocardial infarction.
Lee TM; Chou TF; Tsai CH
J Mol Cell Cardiol; 2003 Dec; 35(12):1449-59. PubMed ID: 14654371
[TBL] [Abstract][Full Text] [Related]
3. Effect of pravastatin on development of left ventricular hypertrophy in spontaneously hypertensive rats.
Lee TM; Lin MS; Chou TF; Tsai CH; Chang NC
Am J Physiol Heart Circ Physiol; 2005 Jul; 289(1):H220-7. PubMed ID: 15665062
[TBL] [Abstract][Full Text] [Related]
4. Effect of pravastatin on ventricular arrhythmias in infarcted rats: role of connexin43.
Chen CC; Lien HY; Hsu YJ; Lin CC; Shih CM; Lee TM
J Appl Physiol (1985); 2010 Aug; 109(2):541-52. PubMed ID: 20466804
[TBL] [Abstract][Full Text] [Related]
5. Effects of pravastatin on ventricular remodeling by activation of myocardial KATP channels in infarcted rats: role of 70-kDa S6 kinase.
Lee TM; Lin MS; Tsai CH; Chang NC
Basic Res Cardiol; 2007 Mar; 102(2):171-82. PubMed ID: 17031758
[TBL] [Abstract][Full Text] [Related]
6. Effect of pravastatin on left ventricular mass in the two-kidney, one-clip hypertensive rats.
Lee TM; Lin MS; Tsai CH; Chang NC
Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H2705-13. PubMed ID: 16798829
[TBL] [Abstract][Full Text] [Related]
7. Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation.
Fliser D; Buchholz K; Haller H;
Circulation; 2004 Aug; 110(9):1103-7. PubMed ID: 15313950
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of balloon injury-induced neointimal formation by olmesartan and pravastatin in rats with insulin resistance.
Chen M; Ichiki T; Ohtsubo H; Imayama I; Inanaga K; Miyazaki R; Sunagawa K
Hypertens Res; 2007 Oct; 30(10):971-8. PubMed ID: 18049030
[TBL] [Abstract][Full Text] [Related]
9. Effect of pravastatin on sympathetic reinnervation in postinfarcted rats.
Lee TM; Lin MS; Chang NC
Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3617-26. PubMed ID: 17890424
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors.
Ishiyama Y; Gallagher PE; Averill DB; Tallant EA; Brosnihan KB; Ferrario CM
Hypertension; 2004 May; 43(5):970-6. PubMed ID: 15007027
[TBL] [Abstract][Full Text] [Related]
11. Effects of combined olmesartan and pravastatin on glucose intolerance and cardiovascular remodeling in a metabolic-syndrome model.
Mizukawa M; Ohmori K; Obayashi A; Ishihara Y; Yoshida J; Noma T; Yukiiri K; Kosaka H; Kohno M
Hypertens Res; 2009 Jul; 32(7):617-24. PubMed ID: 19461650
[TBL] [Abstract][Full Text] [Related]
12. Pravastatin enhances beneficial effects of olmesartan on vascular injury of salt-sensitive hypertensive rats, via pleiotropic effects.
Yamamoto E; Yamashita T; Tanaka T; Kataoka K; Tokutomi Y; Lai ZF; Dong YF; Matsuba S; Ogawa H; Kim-Mitsuyama S
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):556-63. PubMed ID: 17170375
[TBL] [Abstract][Full Text] [Related]
13. Pravastatin and olmesartan synergistically ameliorate renal failure-induced vascular calcification.
Iijima K; Ito Y; Son BK; Akishita M; Ouchi Y
J Atheroscler Thromb; 2014; 21(9):917-29. PubMed ID: 24834982
[TBL] [Abstract][Full Text] [Related]
14. Pravastatin improves remodeling and cardiac function after myocardial infarction by an antiinflammatory mechanism rather than by the induction of angiogenesis.
Li TS; Takahashi M; Suzuki R; Kobayashi T; Ito H; Mikamo A; Hamano K
Ann Thorac Surg; 2006 Jun; 81(6):2217-25. PubMed ID: 16731157
[TBL] [Abstract][Full Text] [Related]
15. Effect of combined treatment with an angiotensin II receptor antagonist and an HMG-CoA reductase inhibitor on atherosclerosis in genetically hyperlipidemic rabbits.
Kato M; Sada T; Mizuno M; Kitayama K; Inaba T; Koike H
J Cardiovasc Pharmacol; 2005 Oct; 46(4):556-62. PubMed ID: 16160612
[TBL] [Abstract][Full Text] [Related]
16. Effect of olmesartan and pravastatin on experimental cerebral aneurysms in rats.
Kimura N; Shimizu H; Eldawoody H; Nakayama T; Saito A; Tominaga T; Takahashi A
Brain Res; 2010 Mar; 1322():144-52. PubMed ID: 20114040
[TBL] [Abstract][Full Text] [Related]
17. Improvement of glucose intolerance by combination of pravastatin and olmesartan in type II diabetic KK-A(y) mice.
Kanno H; Iwai M; Inaba S; Senba I; Nakaoka H; Sone H; Mogi M; Horiuchi M
Hypertens Res; 2009 Aug; 32(8):706-11. PubMed ID: 19478815
[TBL] [Abstract][Full Text] [Related]
18. Pravastatin attenuates left ventricular remodeling and diastolic dysfunction in angiotensin II-induced hypertensive mice.
Xu Z; Okamoto H; Akino M; Onozuka H; Matsui Y; Tsutsui H
J Cardiovasc Pharmacol; 2008 Jan; 51(1):62-70. PubMed ID: 18209570
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat.
Wollert KC; Studer R; Doerfer K; Schieffer E; Holubarsch C; Just H; Drexler H
Circulation; 1997 Apr; 95(7):1910-7. PubMed ID: 9107180
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of combination of ACE inhibitor and angiotensin II type 1 receptor blocker on cardiac remodeling in rat myocardial infarction.
Nakamura Y; Yoshiyama M; Omura T; Yoshida K; Izumi Y; Takeuchi K; Kim S; Iwao H; Yoshikawa J
Cardiovasc Res; 2003 Jan; 57(1):48-54. PubMed ID: 12504813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
